Patents by Inventor Jeremy WULFF

Jeremy WULFF has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240308939
    Abstract: Disclosed herein are embodiments of a bi-functionalized dicyclopentadiene monomer and polymer embodiments formed therefrom. The monomer embodiments exhibit tunability and can be used to form thermally stable homopolymers, copolymers, and/or crosslinked polymers.
    Type: Application
    Filed: March 30, 2022
    Publication date: September 19, 2024
    Applicant: UVIC INDUSTRY PARTNERSHIPS INC.
    Inventors: Jeremy Wulff, Benjamin Godwin
  • Publication number: 20240166849
    Abstract: A family of novel diazirine-based molecules is disclosed, as well as methods of manufacture and uses thereof. These compounds allow non-functionalized polymers, such as polyolefins, to crosslink via C—H insertion. Such a C—H insertion process is useful, for example, for the covalent adhesive bonding of low surface energy films or materials, or for creating rigid 3-dimenional polymeric structures by in-situ doping and activation of the crosslinker. The disclosed crosslinkers can be activated thermally, by UV radiation or by an electric potential.
    Type: Application
    Filed: March 2, 2022
    Publication date: May 23, 2024
    Applicant: XLYNX MATERIALS INC.
    Inventors: Jeremy WULFF, Peter BERRANG, Stefania MUSOLINO, Rashid NAZIR, Liting BI
  • Publication number: 20230136109
    Abstract: A series of novel molecular conjugates is disclosed herein, consisting of a photosensitizer moiety chemically bonded to at least one diazirine moiety. Such conjugates react in air and/or water with non-coherent visible light to form singlet oxygen, an energetic species known to be highly toxic to abroad range of pathogens, including bacteria, fungi, microbial biofilms and viruses. Such non-specific cellular damage limits the pathogen's ability to evolve into a resistant form. The diazirine moiety of the conjugate enables the reagent to be adhesively bonded to a plethora of substrates, such as, for example, polymers, non-woven fabrics, surgical masks and gloves, hospital gowns, hospital surfaces (such as counters, mattresses, curtains) medical implants, bandages, wound dressings, or air-filters. The resulting treated substrates act as an effective pathogen-killing barrier, providing protection against the spread of such pathogens to non-infected persons.
    Type: Application
    Filed: March 4, 2021
    Publication date: May 4, 2023
    Inventors: Heather BUCKLEY, Jeremy WULFF, Peter BERRANG, Mathieu LEPAGE, Stefania MUSOLINO